Organisers & Contacts
ESASO Organising Committee
| President of the ESASO Foundation | Giuseppe Guarnaccia, Italy |
| Vice President of the ESASO Foundation Board | Borja Corcostegui, Spain |
| Member of the ESASO Foundation Board | Francesco Bandello, Italy |
Scientific Committee
| Chairman | Francesco Bandello, Italy |
| Co-Chairs | Neil M. Bressler, USA Marie Hickey Dwyer, Ireland |
| Coordinators | Maurizio Battaglia-Parodi, Italy Bruno Falcomatà, Italy |
ESASO Congress Contacts
| ESASO / ORGANISER | c/o Università della Svizzera italiana Via Lambertenghi 10 A 6904 Lugano, Switzerland |
| General Manager ESASO | Gabriella Skala, Switzerland gabriella.skala@esaso.org Tel. +41 76 300 9000 |
| Scientific Committee Coordinator | Bruno Falcomatà bruno.falcomata@esaso.org Tel. +39 (333) 31 35 566 Maurizio Battaglia-Parodi battagliaparodi.maurizio@esaso.org Tel. +39 (340) 855 9739 |
| Scientific Secretariat | Shetal Gudka, Helen Cox scientific.secretariat@esaso.org shetal.gudka@esaso.org helen.cox@esaso.org Tel. +44 208 326 3121 |
| Logistics and Travel Management | Luisa Marques, Isabel Oliveira congress@esaso.org luisa.marques@esaso.org isabel.oliveira@esaso.org Tel. + 351 214 159 900 |
Scientific Programme
25- 26 October 2013, Dublin, Ireland
The Scientific Committee have developed an engaging scientific programme. Internationally renowned retinal specialists from all continents will present latest news from their fields of research and clinical practice.
You can look forward to:
Clinical presentations:
– 26 plenary presentations
– 6 panel based discussions
– 17 case study presentations
– 2 ESASO Style Debates and 3 ESASO Master Classes
(Sessions concurrent: Delegates to attend one session)
Rewarding achievement:
– Poster exhibition and presentation
– 4th ESASO Graduation Ceremony
– XOVA Award
Scientific Committee
Chair: Francesco Bandello, ITALY
Co-chairs: Neil M. Bressler, USA; Marie Hickey-Dwyer IRELAND
Scientific Committee Co-ordinators
Bruno Falcomata, ITALY
Maurizio Battaglia-Parodi, ITALY
E-Congress 2013
Friday, 25th October
| Opening Ceremony Welcome to Dublin |
Francesco Bandello, Italy Borja Corcóstegui, Spain Giuseppe Guarnaccia, Italy Marie Hickey-Dwyer, Ireland |
| SESSION 1 The Global Challenge of Visual Impairment and Blindness |
Chairs: Marco Zarbin, USA Francesco Bandello, Italy |
| Global burden of visual impairment and blindness | Rupert Bourne, UK |
| eXcellence in Ophthalmology Vision Award (XOVA) | Winner to be announced |
| Low vision rehabilitation: Improving the patient outlook | Gary Rubin, UK |
| Practical applications of stems cells and retinal transplantation | Marco Zarbin, USA |
| Utilizing gene therapy and artificial vision | Deniz Dalkara, France |
| SESSION 2 Clinical Management of Diabetic Macular Edema and Diabetic Retinopathy |
Chairs: Susan Bressler, USA Anat Loewenstein, Israel |
| PDR: Beyond PRP | Neil Bressler, USA |
| Practical management of DME: Selecting the appropriate therapy | Francesco Bandello, Italy |
| Keypad case presentations | Sobha Sivaprasad, UK Paolo Lanzetta, Italy Victor Chong, UK Rafael Navarro, Spain |
| Panel discussion | All |
| SESSION 3 The Long-Term Management of AMD: Efficacy, Safety and Economic Considerations |
Chairs: Paul Mitchell, Australia Gabriel Coscas, France |
| Long-term vision outcomes with anti-VEGF | Paul Mitchell, Australia |
| Are we under-treating our patients in the long term? | Frank Holz, Germany |
| Examining the impact of switching from anti-VEGF therapy | Paolo Lanzetta, Italy |
| Long-term safety and costs: A closer look | Susan Bressler, USA |
| Keypad case presentations | Sobha Sivaprasad, UK Jean-François Korobelnik, France Jordi Monés, Spain Rafael Navarro, Spain |
| Panel discussion | All |
| Poster Awards | Presented by the Chair |
| Partnering to Resolve Unmet Medical Needs in Ophthalmology: Novartis and Alcon R&D Approach |
Sabri Markabi, USA Dirk Sauer, Switzerland |
| SESSION 4 Anti-VEGF Therapies Head-to-Head |
Chairs: Alain Gaudric, France Neil Bressler, USA |
| Bevacizumab versus ranibizumab comparative studies | Usha Chakravarthy, Ireland |
| Ranibizumab versus aflibercept comparative studies | Jean-François Korobelnik, France |
| Putting the patient at the center: Patient-reported outcomes and blindness | Paul Mitchell, Australia |
| The development of geographic atrophy following anti-VEGF therapies | Noemi Lois, UK |
| The treatment of RAP | Adrian Koh, Singapore |
| Optimizing the treatment of PCV | Nagahisa Yoshimura, Japan |
| Panel discussion | All |
| SESSION 5 Making the most of retinal therapies: Recent developments |
Chairs: Susan Bressler, USA Anselm Kampik, Germany |
| RADIANCE study results: Patients with CNV secondary to PM | Francesco Bandello, Italy |
| Moving beyond anti-VEGF therapy: What next for geographic atrophy? | Frank Holz, Germany |
| New drug treatments for wet AMD beyond anti-VEGFs | Marco Zarbin, USA |
| The role of dietary supplements: AREDS2 | Susan Bressler, USA |
| Radiation therapy with anti-VEGF: Strength in unity? | Usha Chakravarthy, Ireland |
| Summary and Close | Francesco Bandello, Italy |
Saturday, 26th October
Accreditation
The ‘13th International AMD and Retina Congress’ has been accredited by The Irish College of
Ophthalmologists and has been designated 8 External and 1 Internal credit points
Congress Information
Congress Venue
The Convention Centre Dublin
Welcome to The Convention Centre Dublin (The CCD), Ireland’s first purpose-built convention centre, located in Spencer Dock
in the heart of Dublin city.
Developed by Treasury Holdings, as part of a Public Private Partnership with the Office of Public Works (OPW), the CCD is the first state-owned, public-access building to be constructed since the foundation of the Irish State.Designed by Pritzker award-winning Irish-born architect Kevin Roche, the CCD has quickly become a landmark building. Its stunning design includes a unique glass-fronted atrium running the full height of the building, which gives visitors panoramic views of the river Liffey, Dublin city centre and the Wicklow mountains.The CCD was designed around the delegate experience and offers 22 multi-functional, flexible rooms suitable for meetings, conferences and exhibitions of all shapes and sizes – from small corporate meetings to international congresses. The entire venue is finished to the highest specifications and incorporates the latest technology throughout.
Congress Details
| Badges for participants | Participants will receive individual name badges when checking in for the Congress. According to the ESASO guidelines, name badges must be worn at all times throughout the Congress and evening functions. |
| Congress Language and Translators | The official Congress language is English. Please take note that simultaneous translation may be provided at the request of respective countries, but will otherwise not be provided. |
| Food and Refreshments | Food and refreshments are not included in the registration fee outside the congress times with the exception of the social events. |
| Insurance(s) | The Organisers are not responsible for individual medical, travel or personal insurances. Delegates are advised to cover themselves with their own personal insurances. |
| Registration Desk – Opening Hours | Official Congress Hotels:
|
| Smoking policy | Smoking is strictly prohibited during all meetings, sessions and in the meeting rooms and halls at all times. |
XOVA
(eXcellence in Ophthalmology Vision Award)
Each year, three or more projects are awarded funding, in the form of a grant, to medical specialists who have devised non-profit, sustainable initiatives that are expected to have a significant positive impact on unmet needs in the field of ophthalmology and optometry. Winning initiatives are selected by the XOVA committee, which comprises over 30 esteemed international experts in eye health.
XOVA welcomes proposed initiatives from around the world, and XOVA 2013 is currently open for applications until 31 July 2013. For more information on the XOVA programme, including details on past XOVA winners and how to apply for the award, please visit the XOVA website at www.xovaprogram.org
The 13th International AMD and Retina Congress is proud to host the XOVA award ceremony, which will be taking place at the Congress Centre, Dublin, Ireland, over 25 and 26 October 2013.
XOVA is fully sponsored by Novartis Pharma and Alcon, and led by medical specialists in the field of eye care.
Grant Givers
This congress is supported by an unrestricted educational grant from:
Media Coverage
EUROTIMES
AMD CONGRESS
International meeting provides update on retinal disease therapy – CLICK HERE TO READ
Irish Medical Independent
Setting our sights on an end to vision impairing illnesses – CLICK HERE TO READ
Irish Medical Independent – Online Coverage
13th International AMD & Retina Congress, Dublin 2013 – CLICK HERE TO READ
Irish Medical News
Giving sight a fighting chance – CLICK HERE TO READ
Irish Medical Times – Online Coverage
Eye services ‘at bursting capacity’ – CLICK HERE TO READ
Breaking news: More than 1,100 eye surgeons set for Dublin meeting – CLICK HERE TO READ
Irish Times Supplement – Online Coverage
Experts now seeing advances on treatment of preventable blindness – CLICK HERE TO READ
The Irish Times currently has a readership of 321,000 daily